CN101850014B - Chinese medicament for treating asthma - Google Patents
Chinese medicament for treating asthma Download PDFInfo
- Publication number
- CN101850014B CN101850014B CN2009100937032A CN200910093703A CN101850014B CN 101850014 B CN101850014 B CN 101850014B CN 2009100937032 A CN2009100937032 A CN 2009100937032A CN 200910093703 A CN200910093703 A CN 200910093703A CN 101850014 B CN101850014 B CN 101850014B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- chinese
- radix
- fine powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating asthma, and belongs to the field of Chinese medicaments for treating respiratory diseases. The Chinese medicament aims to have good effect and quick response. The Chinese medicament is prepared from raw materials such as white mulberry root-bark, radix rehmanniae, semen armeniacae amarum, honey-fried ephedra, glossy ganoderma, radix pseudo-ginseng, Chinese angelica and the like. The Chinese medicament has the effects of strengthening body resistance and archaeus, supplementing qi and nourishing blood, promoting blood circulation by removing blood stasis, dispersing and lowering lung-qi, tonifying the lung and invigorating the spleen and the kidney, and has the advantages of obvious effect, definite curative effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment respiratory disease.
Background technology
At present, be intended to treat the field of Chinese medicines of asthma, exist the deficiency of several aspects: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.Large quantities of asthma patients can not effectively treat and control because of medicine should disease, thus asthma is shown effect repeatedly, touching difficulty more, the patient is sound, unable to lie due to dyspnea in fullness in the chest with rough breath, the larynx usually, and is very painful.Family numbers of patients is very dissatisfied to this.
To problem set forth above, the present invention provides a kind of Chinese medicine of treating asthma, and it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, and effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention realizes through following technical scheme:
1, a kind of Chinese medicine of treating asthma adopts the raw material of Chinese medicine preparation, fill a prescription into (by weight):
Cortex Mori 4---30 parts in 30 parts of Radix Rehmanniae 5---40 parts of Semen Armeniacae Amarums 4---
Herba Ephedrae (processed) 3---20 parts of 20 portions of Ganodermas 2---12 portions of Radix Notoginseng 3---
Radix Angelicae Sinensis 4---30 parts
The Chinese medicine of this treatment asthma is processed by following method:
(1) by above-mentioned weight ratio, Cortex Mori, the Radix Rehmanniae, Semen Armeniacae Amarum, Herba Ephedrae (processed), Radix Angelicae Sinensis are extracted through conventional water extraction process, process the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Rehmanniae benefiting QI and nourishing blood, the body resistance strengthening and constitution consolidating, tonification the five internal organs in the side; Be aided with Cortex Mori, Herba Ephedrae (processed), Semen Armeniacae Amarum dispersing and lowering lung-QI; Radix Angelicae Sinensis, the blood stasis dispelling of Radix Notoginseng blood-enriching and blood-promoting circulation, invigorating liver and spleen.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, dispersing and lowering lung-QI, the merit of tonifying the lung tonifying speen and tonifying kidney, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
Through following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Cortex Mori 80 gram Radix Rehmanniae 100 gram Semen Armeniacae Amarums 80 grams
Herba Ephedrae (processed) 60 kairine sesames 40 gram Radix Notoginseng 60 grams
Radix Angelicae Sinensis 80 grams
Press predetermined weight, Cortex Mori, the Radix Rehmanniae, Semen Armeniacae Amarum, Herba Ephedrae (processed), Radix Angelicae Sinensis are extracted, process extractum fine powder 120 grams with conventional water extraction process; Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Process fine particle; The capsule of packing into No. 0 is processed 785 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
The Cortex Mori 160 gram Radix Rehmanniae 200 gram Semen Armeniacae Amarums 100 grams
Herba Ephedrae (processed) 100 kairine sesames 60 gram Radix Notoginseng 100 grams
Radix Angelicae Sinensis 160 grams
By above-mentioned same method, process 1342 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
The Cortex Mori 300 gram Radix Rehmanniae 400 gram Semen Armeniacae Amarums 300 grams
Herba Ephedrae (processed) 200 kairine sesames 120 gram Radix Notoginseng 200 grams
Radix Angelicae Sinensis 300 grams
By above-mentioned same method, process 2750 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
8 parts in 10 parts of Semen Armeniacae Amarums of 8 parts of Radix Rehmanniae of Cortex Mori
6 parts of 4 portions of Radix Notoginseng of 6 portions of Ganodermas of Herba Ephedrae (processed)
8 parts of Radix Angelicae Sinensis
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
15 parts in 25 parts of Semen Armeniacae Amarums of 25 parts of Radix Rehmanniae of Cortex Mori
15 parts of 9 portions of Radix Notoginseng of 15 portions of Ganodermas of Herba Ephedrae (processed)
15 parts of Radix Angelicae Sinensis
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science asthma, through 8 routine clinical observations.Selecting tcm diagnosis asthma is standard: patient's limb is soft weak, and is weak on one's body; Usually uncomfortable in chest, pant, cough, dyspnea; Asthma is seasonal outbreak, perhaps cold asthma, perhaps asthma of heat type; Fullness in the chest with rough breath during asthma, the sound pitch breath gushes unable to lie due to dyspnea.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 4 examples, women's 4 examples do not have other serious disease, and the age is 57 years old-79 years old, 66.3 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, on one's body energetically; Uncomfortable in chest, cough, dyspnea are obviously alleviated; The asthma attack number of times reduces, and the time is shorter; Took in 2 months in advance, cold asthma or asthma of heat type outbreak probability reduce.
2, effective: body constitution strengthens, on one's body energetically; Uncomfortable in chest, pant, cough, dyspnea alleviate to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.8 philtrums of clinical experiment, produce effects 3 people, effective 4 people, invalid 1 people, total effective rate 87.5%.
Claims (1)
1. a Chinese medicine of treating asthma is characterized in that, said Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Cortex Mori 4---30 parts in 30 parts of Radix Rehmanniae 5---40 parts of Semen Armeniacae Amarums 4---
Herba Ephedrae (processed) 3---20 parts of 20 portions of Ganodermas 2---12 portions of Radix Notoginseng 3---
Radix Angelicae Sinensis 4---30 parts
The Chinese medicine of this treatment asthma is processed by following method:
(1) by above-mentioned weight ratio, Cortex Mori, the Radix Rehmanniae, Semen Armeniacae Amarum, Herba Ephedrae (processed), Radix Angelicae Sinensis are extracted through conventional water extraction process, process the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Process Chinese medicine granules, capsule, watered pill, tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100937032A CN101850014B (en) | 2009-09-25 | 2009-09-25 | Chinese medicament for treating asthma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100937032A CN101850014B (en) | 2009-09-25 | 2009-09-25 | Chinese medicament for treating asthma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101850014A CN101850014A (en) | 2010-10-06 |
| CN101850014B true CN101850014B (en) | 2012-05-23 |
Family
ID=42801804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100937032A Expired - Fee Related CN101850014B (en) | 2009-09-25 | 2009-09-25 | Chinese medicament for treating asthma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101850014B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1031327A (en) * | 1988-07-07 | 1989-03-01 | 买耀华 | A kind of manufacture method for the treatment of the tracheitis, asthma Chinese patent medicine |
-
2009
- 2009-09-25 CN CN2009100937032A patent/CN101850014B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1031327A (en) * | 1988-07-07 | 1989-03-01 | 买耀华 | A kind of manufacture method for the treatment of the tracheitis, asthma Chinese patent medicine |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101850014A (en) | 2010-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843660B (en) | Chinese medicament for treating tachycardia | |
| CN101850017B (en) | Chinese medicament for treating asthma | |
| CN101850014B (en) | Chinese medicament for treating asthma | |
| CN101884704B (en) | Traditional Chinese medicine for treating asthma | |
| CN101897847B (en) | Traditional Chinese medicine for curing asthma | |
| CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101843698B (en) | Chinese medicament for treating cervical spondylosis | |
| CN101843679B (en) | Chinese medicament for treating cervical spondylosis | |
| CN101850055B (en) | Chinese medicament for treating coronary heart diseases | |
| CN101843718B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101884762B (en) | Traditional Chinese medicine for treating emphysema | |
| CN101850018A (en) | Chinese medicament for treating cervical spondylosis | |
| CN101850078B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843717B (en) | Chinese medicament for treating coronary disease | |
| CN101850083B (en) | Chinese medicament for treating asthma | |
| CN101850079B (en) | Chinese medicament for treating asthma | |
| CN101843830B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101879259B (en) | Traditional Chinese medicine for treating pulmonary heart diseases | |
| CN101564476B (en) | Chinese medicament for treating coronary heart disease | |
| CN101843797A (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843844B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843777B (en) | Chinese medicament for treating liver cirrhosis | |
| CN101843832B (en) | Chinese medicament for treating coronary disease | |
| CN101843750B (en) | Chinese medicament for treating chronic nephritis | |
| CN101879246A (en) | Traditional Chinese medicine for treating lupus erythematosus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120523 Termination date: 20120925 |